|XHQLX -- USA Fund|| |
USD 20.92 0.14 0.66%
Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Tekla Life Sciences Investors is 'Hold'
. Macroaxis provides Tekla Life buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding XHQLX positions. The advice algorithm takes into account all of Tekla Life Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from XHQLX buy-and-hold prospective. See also Tekla Life Analyst Recommendation
to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
For the selected time horizon Tekla Life Sciences Investors has a risk adjusted performance of 0.2359, jensen alpha of 0.3378, total risk alpha of 0.1031, sortino ratio of 0.0 and treynor ratio of 1.13
Macroaxis buy or sell recommendation module can be used to complement current analysts and expert consensus
on Tekla Life Sciences. Our recommendation engine harnesses analyzes the fund potential to grow using all fundamental data market data available at the time. Please be advised to validate Tekla Life Number of Employees
to validate our buy or sell recommendation.
Returns Distribution Density
|Mean Return||0.31||Value At Risk||0.00|
|Potential Upside||1.65||Standard Deviation||0.79|
Tekla Life Greeks
Tekla Life Volatility Alert
Tekla Life Sciences Investors exhibits very low volatility with skewness of 3.13 and kurtosis of 10.45. However, we advise investors to further study Tekla Life Sciences Investors technical indicators to make sure all market info is available and is reliable.
Tekla Life Fundamental Vs Peers